Inhibition of pro-inflammatory cytokine generation by CTLA4-Ig in the skin and colon of mice adoptively transplanted with CD45RBhi CD4+ T cells correlates with suppression of psoriasis and colitis
Authors:
- Colleen M DavenportCDColleen M Davenport
- Laura HealyLHLaura Healy
- 1 April 2002
- journal article
- Published by Elsevier in International Immunopharmacology
- Vol. 2 (5) , 653-672
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- CTLA4-Ig: a novel immunosuppressive agentExpert Opinion on Investigational Drugs, 2000
- Predominant pathogenic role of tumor necrosis factor in experimental colitis in miceEuropean Journal of Immunology, 1997
- Inhibition of T cell costimulation abrogates airway hyperresponsiveness in a murine model.Journal of Clinical Investigation, 1996
- Prevention and amelioration of collagen‐induced arthritis by blockade of the CD28 co‐stimulatory pathway: requirement for both B7‐1 and B7‐2European Journal of Immunology, 1996
- Differential recognition by CD28 of its cognate counter receptors CD80 (B7.1) and B70 (B7.2): Analysis by site directed mutagenesisMolecular Immunology, 1996
- Treatment of Murine Lupus with CTLA4IgScience, 1994
- Effect of CTLA‐4 chimeric protein on rat autoimmune anti‐glomerular basement membrane glomerulonephritisEuropean Journal of Immunology, 1994
- Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporinDigestive Diseases and Sciences, 1993
- Immunosuppression in Vivo by a Soluble Form of the CTLA-4 T Cell Activation MoleculeScience, 1992
- Increased concentrations of interleukin 1 beta, interleukin-2, and soluble interleukin-2 receptors in endoscopical mucosal biopsy specimens with active inflammatory bowel disease.Gut, 1992